PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

被引：0

作者：

Humbert, M. ^{[1
]}

Mclaughlin, V. V. ^{[2
]}

Gibbs, S. R. ^{[3
]}

Gomberg-Maitland, M. ^{[4
]}

Hoeper, M. ^{[5
]}

Preston, I. R. ^{[6
]}

Souza, R. ^{[7
]}

Waxman, A. B. ^{[8
]}

Ghofrani, H. A. ^{[9
]}

Subias, P. Escribano ^{[10
]}

Feldman, J. P. ^{[11
]}

Bohns Meyer, G. ^{[12
]}

Montani, D.

Olsson, K. M.

Manimaran, S. ^{[13
]}

Pena, J. de Oliveira ^{[13
]}

Badesch, D. B. ^{[14
]}

机构：

[1] Hop Bicetre, Pneumol, Le Kremlin Bicetre, France

[2] Univ Michigan Hosp, Ann Arbor, MI 48109 USA

[3] Imperial Coll London, London, England

[4] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA

[5] Hannover Med Sch, Dept Resp Med, Hannover, Germany

[6] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA

[7] Univ Sao Paulo, Pulm Div Heart Inst, Med Sch, Sao Paulo, Brazil

[8] Brigham & Womans Hosp, Div Pulm & Crit Care Med, Boston, MA USA

[9] Univ Hosp Giessen & Marburgh GmbH, Giessen, Germany

[10] Hosp Univ 12 Octubre, Madrid, Spain

[11] Arizona Pulm Specialists, Phoenix, AZ USA

[12] Ctr Hipertensao Pulmonar, Porto Alegre, RS, Brazil

[13] Acceleron Pharma Inc, Cambridge, MA USA

[14] Univ Colorado, Aurora, CO USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2150

引用

页数：2

共 50 条

[1] Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Humbert, Marc
McLaughlin, Vallerie
Gibbs, J. Simon R.
Gomberg-Maitland, Mardi
Hoeper, Marius M.
Preston, Ioana R.
Souza, Rogerio
Waxman, Aaron B.
Ghofrani, Hossein-Ardeschir
Subias, Pilar Escribano
Feldman, Jeremy
Meyer, Gisela
Montani, David
Olsson, Karen M.
Manimaran, Solaiappan
Pena, Janethe de Oliveira
Badesch, David B.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (01)
[2] PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
Badesch, David
Gibbs, Simon
Gomberg-Maitland, Mardi
Hoeper, Marius
Mclaughlin, Vallerie
Preston, Ioana
Souza, Rogerio
Waxman, Aaron
Manimaran, Solaiappan
Barnes, Jennifer
Pena, Janethe De Oliveira
Humbert, Marc
Hoeper, Marius M.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[3] PULSAR Study Open-Label Extension: Interim Results from a Phase 2 Study of the Efficacy and Safety of Sotatercept When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Badesch, D. B.
Gibbs, S.
Gomberg-Maitland, M.
Hoeper, M. M.
McLaughlin, V. V.
Preston, I
Souza, R.
Waxman, A. B.
Manimaran, S.
Barnes, J.
Pena, J. de Oliveira
Humbert, M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[4] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
Ivy, Dunbar
Beghetti, Maurice
Juaneda-Simian, Ernesto
Ravindranath, Ramiya
Lukas, Mary Ann
Machlitt-Northen, Sandra
Scott, Nicola
Narita, Jun
Berger, Rolf M. F.
[J]. EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2123 - 2130
[5] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
Dunbar Ivy
Maurice Beghetti
Ernesto Juaneda-Simian
Ramiya Ravindranath
Mary Ann Lukas
Sandra Machlitt-Northen
Nicola Scott
Jun Narita
Rolf M. F. Berger
[J]. European Journal of Pediatrics, 2024, 183 : 2141 - 2153
[6] Long-Term Efficacy of Oral Treprostinil in Subjects with Pulmonary Arterial Hypertension: FREEDOM-EV Open-Label Extension Study
White, R. J.
Broderick, M.
Deng, C. Q.
Grover, R.
Holdstock, L.
Khan, A.
Bohns Meyer, G.
Ng, B.
Pulido Zamudio, T.
Saib, I.
Sepulveda, P.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[7] Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension
Galie, N.
Gaine, S.
Channick, R.
Ghofrani, H. A.
Hoeper, M.
Lang, I.
McLaughlin, V.
Preiss, R.
Rubin, L.
Shiraga, Y.
Simonneau, G.
Sitbon, O.
Tapson, V.
Chin, K.
[J]. EUROPEAN HEART JOURNAL, 2018, 39 : 631 - 632
[8] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Rogério Souza
Marion Delcroix
Nazzareno Galié
Pavel Jansa
Sanjay Mehta
Tomás Pulido
Lewis Rubin
B. K. S. Sastry
Gérald Simonneau
Olivier Sitbon
Adam Torbicki
Neli Boyanova
Liliya Chamitava
Claudia Stein
Richard N. Channick
[J]. Advances in Therapy, 2022, 39 : 4374 - 4390
[9] Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Galie, Nazzareno
Gaine, Sean
Channick, Richard
Coghlan, J. Gerry
Hoeper, Marius M.
Lang, Irene M.
McLaughlin, Vallerie V.
Lassen, Cheryl
Rubin, Lewis J.
Hsu Schmitz, Shu-Fang
Sitbon, Olivier
Tapson, Victor F.
Chin, Kelly M.
[J]. ADVANCES IN THERAPY, 2022, 39 (01) : 796 - 810
[10] Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Nazzareno Galiè
Sean Gaine
Richard Channick
J. Gerry Coghlan
Marius M. Hoeper
Irene M. Lang
Vallerie V. McLaughlin
Cheryl Lassen
Lewis J. Rubin
Shu-Fang Hsu Schmitz
Olivier Sitbon
Victor F. Tapson
Kelly M. Chin
[J]. Advances in Therapy, 2022, 39 : 796 - 810

← 1 2 3 4 5 →